Key result
Elevated cardiometabolic index linked to ~162% greater risk of depressive symptoms.
Why the study?
The study was designed to investigate the association between the cardiometabolic index and depressive symptoms in middle-aged and older Chinese adults.
Does a higher cardiometabolic index increase the risk of depressive symptoms in middle-aged and older Chinese individuals?
Cross-Sectional (n=7,800)
Yes
Does a higher cardiometabolic index increase the risk of depressive symptoms in middle-aged and older Chinese individuals?
Answers are grounded in this paper and cite their sources.
Elevated cardiometabolic index is independently associated with a significantly higher risk of depressive symptoms in middle-aged and older Chinese adults, with a threshold effect at CMI ≥ 0.594.
Objective: This research is aimed at investigating the association between the cardiometabolic index (CMI) and depressive symptoms in Chinese population of middle and older age, using data derived from the CHARLS study. Methods: Using data from 7,800 participants in the 2011-2012 wave of the CHARLS cohort, this cross-sectional analysis concentrated on examining the association between CMI and depressive symptoms, assessed through CESD-10 scores. The study utilized multivariate logistic regression, multiple linear regression, and restricted cubic spline (RCS) models to investigate the link between CMI and depression, with subgroup analyses offering further insights. Sensitivity analyses included propensity score matching and data from 8,457 participants in the 2015-2016 CHARLS wave. Results: In fully adjusted models, higher CMI was significantly associated with an elevated risk of depression, with participants having a CMI ≥ 0.594 showing a 162% higher risk compared to those with lower CMI. The RCS analysis identified a threshold at CMI = 0.594, where participants with CMI ≥ 0.594 had a 162% elevated possibility of depression in comparison to those with CMI < 0.594 [OR = 2.62, 95% CI: 2.36-2.91]. Sensitivity analyses, including propensity score matching and data from the 2015-2016 CHARLS wave, confirmed the robustness of the findings. Conclusion: Our analysis demonstrates that elevated CMI levels are independently correlated with a heightened likelihood of experiencing depressive symptoms, highlighting the significance of metabolic interventions in mitigating depressive tendencies in middle-aged and older individuals.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) conducted a cross-sectional in Depressive symptoms (n=7,800). Cardiometabolic index (CMI) vs. Lower CMI (< 0.594) was evaluated on Depressive symptoms (CESD-10 score ≥ 10) (OR 2.62, 95% CI 2.36-2.91, p=<0.001). Individuals with a cardiometabolic index ≥ 0.594 had a 162% greater risk of depressive symptoms compared to those with an index < 0.594 (OR 2.62).
Synapse has enriched 10 related papers. Consider them for comparative context: